All the news articles and press releases in one place.

Date / Time Source Company Sector Market Cap Announcement
04Oct16 16:35 RNS ANGLE plc Health £296.3m Result of AGM
30Sep16 07:00 RNS ANGLE plc Health £296.3m Research published in Clinical Chemistry
19Sep16 11:14 RNS ANGLE plc Health £296.3m Issue of Equity
09Sep16 16:12 RNS ANGLE plc Health £296.3m Annual Report and Accounts and Notice of AGM
27Jul16 07:00 RNS ANGLE plc Health £296.3m Initiation of 200 patient US ovarian cancer study
19Jul16 07:00 RNS ANGLE plc Health £296.3m Initiation of European ovarian cancer study
15Jul16 07:00 RNS ANGLE plc Health £296.3m Notice of Results
15Jul16 07:00 RNS ANGLE plc Health £296.3m Parsortix gaining traction at EACR Conference
01Jun16 15:04 RNS ANGLE plc Health £296.3m Holding(s) in Company
31May16 16:36 RNS Legal & General Group Plc Various Various Holding(s) in Company
25May16 07:00 RNS ANGLE plc Health £296.3m Placing
25May16 07:00 RNS ANGLE plc Health £296.3m Cancer Research UK Contract
18Apr16 07:00 RNS ANGLE plc Health £296.3m Parsortix potential in metastatic breast cancer
21Mar16 07:00 RNS ANGLE plc Health £296.3m Parsortix potential for prostate cancer detection
09Mar16 07:00 RNS ANGLE plc Health £296.3m European patent grant for Parsortix
28Jan16 07:00 RNS ANGLE plc Health £296.3m Interim Results
27Jan16 10:42 RNS ANGLE plc Health £296.3m Notice of Interim Results
25Jan16 07:00 RNS ANGLE plc Health £296.3m UKE publishes evaluation of Parsortix
22Dec15 07:00 RNS ANGLE plc Health £296.3m Completion of Geomerics Transaction
15Dec15 07:00 RNS ANGLE plc Health £296.3m Parsortix first commercial sales
30Nov15 17:56 RNS ANGLE plc Various Various Holding(s) in Company
17Nov15 07:00 RNS ANGLE plc Health £296.3m Lung Cancer Research Publication
12Nov15 14:17 RNS ANGLE plc Health £296.3m ISSUE OF SHARE OPTIONS
Date / Time Source Company % Chg
04Oct16 16:35 RNS ANGLE plc 4.13%
Result of AGM
30Sep16 07:00 RNS ANGLE plc 4.13%
Research published in Clinical Chemistry
19Sep16 11:14 RNS ANGLE plc 4.13%
Issue of Equity
09Sep16 16:12 RNS ANGLE plc 4.13%
Annual Report and Accounts and Notice of AGM
27Jul16 07:00 RNS ANGLE plc 4.13%
Initiation of 200 patient US ovarian cancer study
19Jul16 07:00 RNS ANGLE plc 4.13%
Initiation of European ovarian cancer study
15Jul16 07:00 RNS ANGLE plc 4.13%
Notice of Results
15Jul16 07:00 RNS ANGLE plc 4.13%
Parsortix gaining traction at EACR Conference
01Jun16 15:04 RNS ANGLE plc 4.13%
Holding(s) in Company
31May16 16:36 RNS Legal & General Group Plc 1.01%
Holding(s) in Company
25May16 07:00 RNS ANGLE plc 4.13%
Placing
25May16 07:00 RNS ANGLE plc 4.13%
Cancer Research UK Contract
18Apr16 07:00 RNS ANGLE plc 4.13%
Parsortix potential in metastatic breast cancer
21Mar16 07:00 RNS ANGLE plc 4.13%
Parsortix potential for prostate cancer detection
09Mar16 07:00 RNS ANGLE plc 4.13%
European patent grant for Parsortix
28Jan16 07:00 RNS ANGLE plc 4.13%
Interim Results
27Jan16 10:42 RNS ANGLE plc 4.13%
Notice of Interim Results
25Jan16 07:00 RNS ANGLE plc 4.13%
UKE publishes evaluation of Parsortix
22Dec15 07:00 RNS ANGLE plc 4.13%
Completion of Geomerics Transaction
15Dec15 07:00 RNS ANGLE plc 4.13%
Parsortix first commercial sales
30Nov15 17:56 RNS ANGLE plc 4.13%
Holding(s) in Company
17Nov15 07:00 RNS ANGLE plc 4.13%
Lung Cancer Research Publication
12Nov15 14:17 RNS ANGLE plc 4.13%
ISSUE OF SHARE OPTIONS